What would it take to change their journey ahead?
In rrRCC, the potential benefit of treatment may be hindered by poor tolerability;
if patients decline or cannot tolerate treatment, they do not have an opportunity to realize its potential benefits.
This site is intended for US healthcare professionals.
After multiple prior treatments in renal cell carcinoma (RCC)
THE JOURNEY CAN QUICKLY BECOME A CHALLENGE